FusionPharm Clarifies LOI With Lehi Roller Mills

DENVER, Oct. 3, 2011 /PRNewswire/ -- FusionPharm Inc. (pinksheets: FSPM), Due to the overwhelming call volume from its earlier press release, the Company would like to clarify that the LOI with Lehi Roller Mills is non-binding and that the two companies are in the very early stages of negotiation.  No definitive agreement, timetable or specific details have been agreed to at this time.

About FusionPharm Inc.

FusionPharm Inc. ( http://www.fusionpharminc.com ). FusionPharm is the creator and manufacturer of GroPods ™ cultivation containers and is actively pursuing expansion into the natural foods marketplace.  

Notes About Forward-Looking Statements:

Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made. For more information about GroPods or any of FusionPharm Inc.'s products or services, call them at 720-458-0686 or view them on the web at http://www.fusionpharminc.com.

SOURCE FusionPharm Inc.

Copyright 2011 PR Newswire